Published Online:
December 7, 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the efficacy and safety of specific allergen immunotherapy, including subcutaneous and sublingual immunotherapy, compared with placebo or standard treatment in people with atopic eczema.